Section Arrow
BBNX.NASDAQ
- Beta Bionics Inc
Quotes are at least 15-min delayed:2026/04/25 20:28 EDT
Regular Hours
Last
 11.17
-0.26 (-2.27%)
Day High 
11.595 
Prev. Close
11.43 
1-M High
13.35 
Volume 
799.86K 
Bid
11
Ask
11.8
Day Low
10.82 
Open
11.35 
1-M Low
8.8 
Market Cap 
509.34M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 11.83 
20-SMA 10.97 
50-SMA 11.58 
52-W High 32.71 
52-W Low 8.8 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.37/-2.33
Enterprise Value
514.71M
Balance Sheet
Book Value Per Share
6.09
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
100.25M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ITOCiTonic Holdings Ltd.0.374+0.0744+24.83%-- 
BSXBoston Scientific Corp62.07-3.62-5.51%33.94PE
ABTAbbott Laboratories91.13-1.35-1.46%24.75PE
EWEdwards Lifesciences Corp84.15+4.43+5.56%45.45PE
PACBPacific Biosciences of California1.56-0.01-0.64%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and saleof the iLet.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.